Profile
RNXT VRTX ALNY REGN ARGX SGEN
Company Name RenovoRx, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $46.91M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.01K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Shaun R. Bagai Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
RNXT VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
RNXT VRTX ALNY REGN ARGX SGEN
Last Close $1.28 $394.53 $465.89 $560 $756.38 $228.74
High 52 $1.54 $516.74 $482.13 $1153.35 $768 $228.74
Low 52 $0.77 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -16.88 % -23.65 % -3.37 % -51.45 % -1.51 % 0 %
Price vs. 52 Week Low 66.23 % 7.64 % 107.45 % 15.96 % 45.52 % 0 %
Total Return
RNXT VRTX ALNY REGN ARGX SGEN
1 Month Return 4.92 % -0.35 % 7.72 % -0.23 % 17.12 % 0 %
3 Month Return -1.54 % -13.38 % 51.27 % 5.81 % 30.89 % 0 %
6 Month Return 25.49 % -21.55 % 92.72 % -17.72 % 30.11 % 0 %
9 Month Return 0.79 % -14.89 % 89.96 % -23.38 % 24.72 % 0 %
YTD Return -0.78 % -2.03 % 97.99 % -21.38 % 22.99 % 0 %
1 Year Return 13.73 % -18.72 % 75.63 % -51.45 % 40.59 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RNXT VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -736.21 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
RNXT VRTX ALNY REGN ARGX SGEN
Asset Growth 453.75 % -0.87 %
Gross Profit Growth - 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -7.21 % -93.69 %
Net Income Growth 13.86 % -114.8 %
Net Income 3 Yeari Growth Per Share 5.98 % -122.89 %
Net Income 5 Yeari Growth Per Share -71.3 % -145.38 %
Net Income 10 Yeari Growth Per Share -71.3 % 33.84 %
Operating Income Growth 3.74 % -106.08 %
Operating Cash Flow Growth (CFG) 11.05 % -113.93 %
Operating 3 Year CFG -16.75 % -118.65 %
Operating 5 Year CFG -99.9 % -131.3 %
Operating 10 Year CFG -99.9 % 12.43 %
EPS Growth 26 % -114.8 %
EPS Diluted Growth 26 % -114.97 %
Book Value Per Share 230.14 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -77.92 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 130.08 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 130.08 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth - 116.42 %
Free Cash Flow Growth 10.93 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
RNXT VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 62.84 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -78.16 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -120.68 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -93.06 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 94.81 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -1699.09 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -3964.23 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 1.82 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.37 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 266.94 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 4.85 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.28 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.28 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 33.67 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -1556.95 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.14 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -3964.23 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -4.54 29.05 -1179.18 15.08 -596.23 -81.26
Price To Operating Cash Flows Ratio TTM -4.54 26.46 -3910.39 12.33 -706.81 -93.1
Price Cash Flow Ratio TTM -4.54 26.46 -3910.39 12.33 -706.81 -93.1
Income Statement (TTM)
RNXT VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.37 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
RNXT VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
RNXT VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.46
AARD Aardvark Therapeutics, Inc. Common Stock 8.59
ABCL AbCellera Biologics Inc. 4.47
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.43
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.32
ABPWW 0.0462
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 4.46
ABVC ABVC BioPharma, Inc. 2.85
ABVX Abivax SA American Depositary Shares 84.01
ACAD ACADIA Pharmaceuticals Inc. 23.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8102
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.08
ACIU AC Immune SA 2.43
ETFs With Exposure to RNXT
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00007 324.31
VXF Vanguard Extended Market Index Fund 0.00047 208.84
IWC iShares Micro-Cap ETF 0.00269 145.77
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00037 52.3
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00037 52.29
VTSAX Vanguard Total Stock Market Index Fund 0 157.86
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00047 158.47
VITSX Vanguard Total Stock Market Index Fund 0 157.89
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000244559 15.95
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00047 158.48
VTS.AX Vanguard US Total Market Shares Index ETF 0.00007 488
VEMPX Vanguard Extended Market Index InstlPlus 0.00047 391.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00007 296.18
Unlock